Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

4.53
-0.4700-9.40%
Post-market: 4.570.0400+0.88%18:01 EDT
Volume:578.58K
Turnover:2.65M
Market Cap:23.41M
PE:0.00
High:4.94
Open:4.82
Low:4.37
Close:5.00
52wk High:1,152.61
52wk Low:2.35
Shares:5.17M
Float Shares:436.90K
Volume Ratio:0.06
T/O Rate:132.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2,338.1604
EPS(LYR):-12,059.1987
ROE:-548.83%
ROA:-38.04%
PB:3.54
PE(LYR):0.00

Loading ...

Jaguar Health announces additional infant to receive crofelemer powder

TIPRANKS
·
Jul 22

Jaguar Health Announces Press Release on Crofelemer Compassionate Use for Infant MVID Patient in EU

Reuters
·
Jul 22

Jaguar Health - Registers Resale of up to 40.8 Mln Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Jul 16

Jaguar Animal Health Signs New Crofelemer Supply Agreement

TIPRANKS
·
Jul 15

Jaguar Health Signs New Crofelemer Manufacturing, Supply Deal with Alivus Through March 2029

Reuters
·
Jul 15

Jaguar Health - Napo and Alivus Enter New Manufacturing and Supply Agreement for Crofelemer on July 9, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 15

Jaguar Health - 2026 Agreement Set to Expire on March 31, 2029 - SEC Filing

THOMSON REUTERS
·
Jul 15

Jaguar Health Completes Series O Preferred Conversion into Common Shares at 3.209-to-1 Ratio

Reuters
·
Jul 02

Jaguar Health provides recap of presentations of crofelemer at ESPGHAN

TIPRANKS
·
Jun 30

Jaguar Health Says Pediatric Intestinal Failure Trial Data Show Crofelemer Cuts Parenteral Support Needs up to 48%

Reuters
·
Jun 30

Jaguar Animal Health Converts Series O Preferred to Common

TIPRANKS
·
Jun 25

Jaguar Health Triggers Conversion of Series O Preferred Shares into Common Stock at 3.209-to-1 Ratio

Reuters
·
Jun 25

Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy

MT Newswires Live
·
Jun 23

Jaguar Health completes FDA submission seeking full approval of Canalevia-CA1 for dog chemo diarrhea

Reuters
·
Jun 23

Jaguar Health - Strategic Alternatives May Include Mergers, Acquisitions, Partnerships, or Licensing - SEC Filing

THOMSON REUTERS
·
Jun 22

Jaguar Health - Board Initiates Process to Explore Strategic Alternatives - SEC Filing

THOMSON REUTERS
·
Jun 22

Jaguar Health Explores Strategic Alternatives

MT Newswires Live
·
Jun 22

Jaguar Health CEO presents crofelemer rare intestinal failure update at Life Sciences Virtual Investor Forum

Reuters
·
Jun 22

Jaguar Health extends Streeterville promissory note maturity to Oct. 1, 2026

Reuters
·
Jun 19

Magdalena Biosciences announces results from preclinical study of coca

TIPRANKS
·
Jun 18